Major Depressive Disorder and Stroke Risks: A 9-Year Follow-Up Population-Based, Matched Cohort Study

作者：Li Cheng Ta^*; Bai Ya Mei; Tu Pei Chi; Lee Ying Chiao; Huang Yu Lin; Chen Tzeng Ji; Chang Wen Han; Su Tung Ping

来源：PLos One, 2012, 7(10): e46818.

DOI：10.1371/journal.pone.0046818

Background and Purpose: Major depressive disorder (MDD) is characterized by recurrent depressive episodes and one of the treatment choices is antidepressants. Patients with MDD are at greater risk of developing major metabolic diseases that may in turn lead to stroke. Moreover, both depressive symptoms and taking antidepressant medications are associated with higher risk of stroke. However, whether and how clinical depression increases stroke risk remains an unanswered question. Our aim was to provide answers to this question. %26lt;br%26gt;Methods: A matched cohort study of 5015 subjects (1003 MDD patients and 4012 control subjects) was conducted using a nationwide database. Subjects were followed to a maximum of 9 years to determine rates of newly-developed strokes, and controls and MDD groups with different levels of antidepressant refractoriness were compared to determine the temporal relation between stroke and three major metabolic comorbidities (i.e., diabetes mellitus, hypertension and hyperlipidemia). The levels of depressive symptoms and the antidepressant medications before stroke onset were investigated. %26lt;br%26gt;Results: Patients with MDD had significantly higher rates of stroke (4.3% vs. 2.8%, p %26lt; 0.05) during the follow-up. Mediation regression analyses revealed that the occurrence of stroke in the MDD subjects was significantly mediated by the development of major metabolic diseases. Greater severity of depression, but not greater use of antidepressants, preceded the occurrence of stroke. %26lt;br%26gt;Conclusions: A clinical diagnosis of major depression leads to stroke indirectly through more intense depressive symptoms and the development of major comorbidities.

• 出版日期2012-10-8